Evidence mapPaperPMID 23685938Full record

ReviewMolecules (Basel, Switzerland)2013

Vasodilator compounds derived from plants and their mechanisms of action.

Francisco J Luna-Vázquez, César Ibarra-Alvarado, Alejandra Rojas-Molina, Isela Rojas-Molina, Miguel Angel Zavala-Sánchez

Open access · goldAbstract readHistorical ArticleReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Vasorelaxant effects of the edible flowersPharmaceutical biology · 2025
    Article
  5. LC-HRMS/MS-Guided Profiling and Biological Evaluation ofMolecules (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Vasorelaxing effect ofJournal of traditional and complementary medicine · 2023
    Article
  8. Article
  9. Article
  10. Vasorelaxant Effect ofMolecules (Basel, Switzerland) · 2022
    Article
  11. Vasodilatory Effect ofMolecules (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Secondary Metabolites of Plants as Modulators of Endothelium Functions.International journal of molecular sciences · 2021
    Review
  14. Review
  15. International journal of molecular sciences · 2020
    Review
  16. Major flavonoids fromJournal of advanced research · 2020
    Article
  17. Article
  18. Article
  19. 8-Oxo-9-Dihydromakomakine Isolated fromMolecules (Basel, Switzerland) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Francisco J Luna-VázquezDoctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Unidad Xochimilco, México, D.F. 04960, Mexico.
César Ibarra-Alvarado
Alejandra Rojas-Molina
Isela Rojas-Molina
Miguel Angel Zavala-Sánchez
Autonomous University of Queretaro · MXUniversidad Autónoma Metropolitana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present paper reviews vasodilator compounds isolated from plants that were reported in the past 22 years (1990 to 2012) and the different mechanisms of action involved in their vasodilator effects. The search for reports was conducted in a comprehensive manner, intending to encompass those metabolites with a vasodilator effect whose mechanism of action involved both vascular endothelium and arterial smooth muscle. The results obtained from our bibliographic search showed that over half of the isolated compounds have a mechanism of action involving the endothelium. Most of these bioactive metabolites cause vasodilation either by activating the nitric oxide/cGMP pathway or by blocking voltage-dependent calcium channels. Moreover, it was found that many compounds induced vasodilation by more than one mechanism. This review confirms that secondary metabolites, which include a significant group of compounds with extensive chemical diversity, are a valuable source of new pharmaceuticals useful for the treatment and prevention of cardiovascular diseases.

Indexed as

Vasodilator AgentsAnimalsCardiovascular DiseasesCyclic GMPEndothelium, VascularHistory, 20th CenturyHistory, 21st CenturyHumansMuscle, Smooth, VascularNitric OxidePlants, MedicinalCyclic GMPNitric OxideVasodilator Agents

Identifiers

PMID23685938
PMCPMC6270466
OpenAlexW1979497398

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.